Adverse Events After BNT162b2 Do Not Differ for Cancer Patients; Among patients with cancer, pain at the injection site was less likely after dose 1 for those receiving active treatment.

Media coverage

• Title	Adverse Events After BNT162b2 Do Not Differ for Cancer Patients; Among patients with cancer, pain at the injection site was less likely after dose 1 for those receiving active treatment.
  Media name/outlet	Physician's Briefings
  Country/Territory	United States
  Date	02/8/22
  Persons	Rebecca M. Shulman